SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
6/23/23 |
| Satvat Ali J. | |||
---|---|---|---|---|---|
11/12/14 |
| Satvat Ali J |
• | List all Filings as Signatory |
• | Search Recent Filings (as Signatory) for “Ali J. Satvat” |
As Of | Filer | Filings # Latest | Issuer (Primary) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
3/28/24 |
| Coherus BioSciences, Inc. | 12 | S-8 | — | ||||||
2/22/24 |
| BridgeBio Pharma, Inc. | 7 | 10-K | — | ||||||
6/24/22 |
| Satvat Ali J. | 4 | 4 |
| BridgeBio Pharma, Inc. | |||||
5/7/21 |
| KKR Iris Investors LLC | 1 | SC 13D |
| IPI Legacy Liquidation Co. | |||||
4/2/21 |
| IPI Legacy Liquidation Co. | 2 | S-1 | — | ||||||
2/17/21 |
| KKR Genetic Disorder L.P. | 2 | SC 13D/A |
| BridgeBio Pharma, Inc. | |||||
12/15/20 |
| Eidos Therapeutics, Inc. | 3 | DEFM14A | — |
As Of | Issuer | Filings # Latest | With Filer (Primary) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
6/24/22 |
| BridgeBio Pharma, Inc. | 4 | 4 |
| Satvat Ali J. | |||||
5/7/21 |
| IPI Legacy Liquidation Co. | 1 | SC 13D |
| KKR Iris Investors LLC | |||||
10/6/20 |
| Eidos Therapeutics, Inc. | 2 | 425 |
| Eidos Therapeutics, Inc. | |||||
11/6/14 |
| Coherus BioSciences, Inc. | 1 | 3 |
| Satvat Ali J. |